{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:15:29Z","timestamp":1767665729063,"version":"3.41.2"},"reference-count":77,"publisher":"Siapec Servizi Srl","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-559","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T10:40:52Z","timestamp":1645785652000},"page":"64-78","source":"Crossref","is-referenced-by-count":9,"title":["New insights in gastrointestinal \u201cpediatric\u201d neoplasms in adult patients: pancreatoblastoma, hepatoblastoma and embryonal sarcoma of the liver. A practical approach by GIPPI-GIPAD Groups"],"prefix":"10.32074","volume":"114","author":[{"given":"Vassilena","family":"Tsvetkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Magro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Broggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Cappello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Caporalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Buccoliero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21774","published-online":{"date-parts":[[2022,2]]},"reference":[{"key":"10.32074\/1591-951X-559_ref1","unstructured":"WHO Classification of Tumors Editorial Board. WHO Classification of Gastro-Intestinal Tumors, 5th Edition. 2019"},{"key":"10.32074\/1591-951X-559_ref2","doi-asserted-by":"crossref","unstructured":"Luchini C, Grillo F, Fassan M, et al. Malignant epithelial\/exocrine tumors of the pancreas. Pathologica 2020;112:210-226. https:\/\/doi.org\/10.32074\/1591-951X-167","DOI":"10.32074\/1591-951X-167"},{"key":"10.32074\/1591-951X-559_ref3","doi-asserted-by":"crossref","unstructured":"Mylonas KS, Nasioudis D, Tsilimigras DI, et al. A population-based analysis of a rare oncologic entity: malignant pancreatic tumors in children. J Pediatr Surg 2018;53:647-652. https:\/\/doi.org\/10.1016\/j.jpedsurg.2017.06.024","DOI":"10.1016\/j.jpedsurg.2017.06.024"},{"key":"10.32074\/1591-951X-559_ref4","doi-asserted-by":"crossref","unstructured":"Shorter NA, Glick RD, Klimstra D, et al. Malignant pancreatic tumors in childhood and adolescence: the Memorial Sloan-Kettering experience, 1967 to present. J Pediatr Surg 2002;37:887-892. https:\/\/doi.org\/10.1053\/jpsu.2002.32897","DOI":"10.1053\/jpsu.2002.32897"},{"key":"10.32074\/1591-951X-559_ref5","doi-asserted-by":"crossref","unstructured":"Klimstra DS, Wenig BM, Adair CF, et al. Pancreatoblastoma: a clinicopathologic study and review of the literature. Am J Surg Pathol 1995;19:1371-1389. https:\/\/doi.org\/10.1097\/00000478-199512000-00005","DOI":"10.1097\/00000478-199512000-00005"},{"key":"10.32074\/1591-951X-559_ref6","doi-asserted-by":"crossref","unstructured":"Muguerza R, Rodriguez A, Formigo E, et al. Pancreatoblastoma associated with incomplete Beckwith-Wiedemann syndrome: case report and review of the literature. J Pediatr Surg 2005;40:1341-1344. https:\/\/doi.org\/10.1016\/j.jpedsurg.2005.05.025","DOI":"10.1016\/j.jpedsurg.2005.05.025"},{"key":"10.32074\/1591-951X-559_ref7","doi-asserted-by":"crossref","unstructured":"Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome. Eur J Hum Genet 2010;18:8-14. https:\/\/doi.org\/10.1038\/ejhg.2009.106","DOI":"10.1038\/ejhg.2009.106"},{"key":"10.32074\/1591-951X-559_ref8","doi-asserted-by":"crossref","unstructured":"Abraham SC, Wu TT, Klimstra DS, et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC\/beta-catenin pathway and chromosome 11p. Am J Pathol 2001;159:1619-1627. https:\/\/doi.org\/10.1016\/s0002-9440(10)63008-8","DOI":"10.1016\/S0002-9440(10)63008-8"},{"key":"10.32074\/1591-951X-559_ref9","doi-asserted-by":"crossref","unstructured":"Defachelles AS, Martin De Lassale E, Boutard P, et al. Pancreatoblastoma in childhood: clinical course and therapeutic management of seven patients. Med Pediatr Oncol 2001;37:47-52. https:\/\/doi.org\/10.1002\/mpo.1162","DOI":"10.1002\/mpo.1162"},{"key":"10.32074\/1591-951X-559_ref10","doi-asserted-by":"crossref","unstructured":"Rajpal S, Warren RS, Alexander M, et al. Pancreatoblastoma in adult: case report and review of the literature. J Gastrointest Surg 2006;10829-836. https:\/\/doi.org\/10.1016\/j.gassur.2005.11.011","DOI":"10.1016\/j.gassur.2005.11.011"},{"key":"10.32074\/1591-951X-559_ref11","doi-asserted-by":"crossref","unstructured":"Kletter GB, Sweetser DA, Wallace SF, et al. Adrenocorticotropin-secreeting pancreatoblastoma. J Pediatr Endocrinol Metab 2007;20:639-642. https:\/\/doi.org\/10.1515\/jpem.2007.20.5.639","DOI":"10.1515\/JPEM.2007.20.5.639"},{"key":"10.32074\/1591-951X-559_ref12","doi-asserted-by":"crossref","unstructured":"Passmore SJ, Berry PJ, Oakhill A. Recurrent pancreatoblastoma with inappropriate adenocorticotrophic hormone secretion. Arch Dis Child 1988;63:1494-1496. https:\/\/doi.org\/10.1136\/adc.63.12.1494","DOI":"10.1136\/adc.63.12.1494"},{"key":"10.32074\/1591-951X-559_ref13","doi-asserted-by":"crossref","unstructured":"Quereshi SS, Bhagat M, KurkurePA, et al. Ectopic Cushing syndrome secondary to recurrent pancreatoblastoma in a child: lessons learnt. J Cancer Res Ther 2015;11:1027. https:\/\/doi.org\/10.4103\/0973-1482.151854","DOI":"10.4103\/0973-1482.151854"},{"key":"10.32074\/1591-951X-559_ref14","doi-asserted-by":"crossref","unstructured":"Ohike N, Morohoshi T. Exocrine pancreatic neoplasms of nonductal origin: acinar cell carcinoma, pancreatoblastoma, and solid-pseudopapillary neoplasm. Surg Pathol Clin 2011;4:579-588. https:\/\/doi.org\/10.1016\/j.path.2011.03.001","DOI":"10.1016\/j.path.2011.03.001"},{"key":"10.32074\/1591-951X-559_ref15","doi-asserted-by":"crossref","unstructured":"Drut R, Jones MC. Congenital pancreatoblastoma in Beckwith-Wiedemann syndrome: an emerging association. Pediatr Pathol 1988;8:331-339. https:\/\/doi.org\/10.3109\/15513818809042976","DOI":"10.3109\/15513818809042976"},{"key":"10.32074\/1591-951X-559_ref16","doi-asserted-by":"crossref","unstructured":"Reid MD, Bhattarai S, Graham RP, et al. Pancreatoblastoma: cytologic and histologic analysis of 12 adult cases reveals helpful criteria in their diagnosis and distinction from common mimics. Cancer Cytopathol 2019;127:708-719. https:\/\/doi.org\/10.1002\/cncy.22187","DOI":"10.1002\/cncy.22187"},{"key":"10.32074\/1591-951X-559_ref17","unstructured":"Tanaka Y, Ijiri R, Yamanaka S, et al. Pancreatoblastoma: optically clear nuclei in squamoid corpuscles are rich in biotin. Mod Pathol 1998;11:945-9."},{"key":"10.32074\/1591-951X-559_ref18","doi-asserted-by":"crossref","unstructured":"Lawlor RT, Dapr\u00e0 V, Girolami I, et al. CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas. Virchows Arch 2019;474:105-109. https:\/\/doi.org\/10.1007\/s00428-018-2437-7","DOI":"10.1007\/s00428-018-2437-7"},{"key":"10.32074\/1591-951X-559_ref19","doi-asserted-by":"crossref","unstructured":"Isobe T, Seki M, Yoshida K, et al. Integrated molecular characterization of the lethal pediatric cancer pancreatoblastoma. Cancer Res 2018;78:865-876. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2581","DOI":"10.1158\/0008-5472.CAN-17-2581"},{"key":"10.32074\/1591-951X-559_ref20","doi-asserted-by":"crossref","unstructured":"Jiao Y, Yonescu R, Offerhaus GJ, et al. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol 2014;232:428-435. https:\/\/doi.org\/10.1002\/path.4310","DOI":"10.1002\/path.4310"},{"key":"10.32074\/1591-951X-559_ref21","doi-asserted-by":"crossref","unstructured":"Dhebri AR, Connor S, Campbell F, et al. Diagnosis, treatment and outcome of pancreatoblastoma. Pancreatology 2004;4:441-51, discussion 452-453. https:\/\/doi.org\/10.1159\/000079823","DOI":"10.1159\/000079823"},{"key":"10.32074\/1591-951X-559_ref22","doi-asserted-by":"crossref","unstructured":"Raoul JL, Oziel-Taieb S, Lecomte T, et al. Case report: two cases of metastatic pancreatoblastoma in adults: efficacy of Folfirinox and implication of the Wnt\/\u03b2-Catenin pathway in genomic analysis. Front Oncol 2021;11:564506. https:\/\/doi.org\/10.3389\/fonc.2021.564506","DOI":"10.3389\/fonc.2021.564506"},{"key":"10.32074\/1591-951X-559_ref23","doi-asserted-by":"crossref","unstructured":"Yang Z, Gong Y, Ji M, et al. Differential diagnosis of pancreatoblastoma (PB) and solid pseudopapillary neoplasms (SPNs) in children by CT and MR imaging. Eur Radiol 2021;31:2209-2217. https:\/\/doi.org\/10.1007\/s00330-020-07309-3","DOI":"10.1007\/s00330-020-07309-3"},{"key":"10.32074\/1591-951X-559_ref24","doi-asserted-by":"crossref","unstructured":"Huang Y, Yang W, Hu J, et al. Diagnosis and treatment of pancreatoblastoma in children: a retrospective study in a single pediatric center. Pediatr Surg Int 2019;35:1231-1238. https:\/\/doi.org\/10.1007\/s00383-019-04524-y","DOI":"10.1007\/s00383-019-04524-y"},{"key":"10.32074\/1591-951X-559_ref25","doi-asserted-by":"crossref","unstructured":"Spector LG, Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer 2012;59:776-779. https:\/\/doi.org\/10.1002\/pbc.24215","DOI":"10.1002\/pbc.24215"},{"key":"10.32074\/1591-951X-559_ref26","doi-asserted-by":"crossref","unstructured":"Allan BJ, Parikh PP, Diaz S, et al. Predictors of survival and incidence of hepatoblastoma in the pediatric population. HPB (Oxford) 2013;15:741-746. https:\/\/doi.org\/10.1111\/hpb.12112","DOI":"10.1111\/hpb.12112"},{"key":"10.32074\/1591-951X-559_ref27","doi-asserted-by":"crossref","unstructured":"Feusner J. Prematurity and hepatoblastoma: more than just an association? J Pediatr 1998;133:585-586. https:\/\/doi.org\/10.1016\/s0022-3476(98)70084-8","DOI":"10.1016\/S0022-3476(98)70084-8"},{"key":"10.32074\/1591-951X-559_ref28","doi-asserted-by":"crossref","unstructured":"Venkatramani R, Spector LG, Georgieff M, et al. Congenital abnormalities and hepatoblastoma: a report from the Children\u2019s Oncology Group (COG) and the Utah Population Database (UPDB). Am J Med Genet A. 2014;164A:2250-2255. https:\/\/doi.org\/10.1002\/ajmg.a.36638","DOI":"10.1002\/ajmg.a.36638"},{"key":"10.32074\/1591-951X-559_ref29","doi-asserted-by":"crossref","unstructured":"Clericuzio CL, Chen E, McNeil DE, et al. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 2003;143:270-272. https:\/\/doi.org\/10.1067\/S0022-3476(03)00306-8","DOI":"10.1067\/S0022-3476(03)00306-8"},{"key":"10.32074\/1591-951X-559_ref30","doi-asserted-by":"crossref","unstructured":"Harvey J, Clark S, Hyer W, Hadzie N, et al. Germline APC mutations are not commonly seen in children with sporadic hepatoblastoma. J Pediatr Gastroenterol Nutr 2008; 4:675-677. https:\/\/doi.org\/10.1097\/MPG.0b013e318174e808","DOI":"10.1097\/MPG.0b013e318174e808"},{"key":"10.32074\/1591-951X-559_ref31","doi-asserted-by":"crossref","unstructured":"Schraw JM, Desrosiers TA, Nembhard WN, et al. Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases. Cancer 2020;126:3483-3492. https:\/\/doi.org\/10.1002\/cncr.32982","DOI":"10.1002\/cncr.32982"},{"key":"10.32074\/1591-951X-559_ref32","doi-asserted-by":"crossref","unstructured":"Schnater JM, K\u00f6hler SE, Lamers WH, et al. Where do we stand with hepatoblastoma? A review. Cancer. 2003; 98:668-678. https:\/\/doi.org\/10.1002\/cncr.11585","DOI":"10.1002\/cncr.11585"},{"key":"10.32074\/1591-951X-559_ref33","doi-asserted-by":"crossref","unstructured":"Litten JB, Tomlinson GE. Liver tumors in children. Oncologist 2008;13:812-820. https:\/\/doi.org\/10.1634\/theoncologist.2008-0011","DOI":"10.1634\/theoncologist.2008-0011"},{"key":"10.32074\/1591-951X-559_ref34","doi-asserted-by":"crossref","unstructured":"Celotti A, D\u2019Amico G, Ceresoli M, et al. Hepatoblastoma of the adult: A systematic review of the literature. Surgical Oncology 2016;25:339-347. https:\/\/doi.org\/10.1016\/j.suronc.2016.07.003","DOI":"10.1016\/j.suronc.2016.07.003"},{"key":"10.32074\/1591-951X-559_ref35","doi-asserted-by":"crossref","unstructured":"Towbin AJ, Meyers RL, Woodley H, et al. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Pediatric Hepatic International Tumor Trial (PHITT). Pediatr Radiol 2018;48:536-544. https:\/\/doi.org\/10.1007\/s00247-018-4078-z","DOI":"10.1007\/s00247-018-4078-z"},{"key":"10.32074\/1591-951X-559_ref36","doi-asserted-by":"crossref","unstructured":"Schooler GR, Squires JH, Alazraki A, et al. Pediatric Hepatoblastoma, Hepatocellular Carcinoma, and Other Hepatic Neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group. Radiology 2020;296:493-497. https:\/\/doi.org\/10.1148\/radiol.2020200751","DOI":"10.1148\/radiol.2020200751"},{"key":"10.32074\/1591-951X-559_ref37","doi-asserted-by":"crossref","unstructured":"Finegold MJ, Lopez-Terrada D, Bowen J, et al. Protocol for the examination of specimens from pediatric patients with hepatoblastoma. Arch Pathol Lab Med 2007;131:520-529. https:\/\/doi.org\/10.5858\/2007-131-520-PFTEOS","DOI":"10.5858\/2007-131-520-PFTEOS"},{"key":"10.32074\/1591-951X-559_ref38","doi-asserted-by":"crossref","unstructured":"Lopez-Terrada D, Alaggio R, de Davila MT, et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol. 2014;27:472-491. https:\/\/doi.org\/10.1038\/modpathol.2013.80","DOI":"10.1038\/modpathol.2013.80"},{"key":"10.32074\/1591-951X-559_ref39","doi-asserted-by":"crossref","unstructured":"Ranganathan S, Lopez-Terrada D, Alaggio R. Hepatoblastoma and pediatric hepatocellular carcinoma: an update. Pediatr Dev Pathol 2020;23:79-95. https:\/\/doi.org\/10.1177\/1093526619875228","DOI":"10.1177\/1093526619875228"},{"key":"10.32074\/1591-951X-559_ref40","doi-asserted-by":"crossref","unstructured":"Meyer RL, Maibach R, Hiyama E, et al. Risk-stratified staging in pediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration. Lancet Oncol 2017;18:122-131. https:\/\/doi.org\/10.1016\/S1470-2045(16)30598-8","DOI":"10.1016\/S1470-2045(16)30598-8"},{"key":"10.32074\/1591-951X-559_ref41","doi-asserted-by":"crossref","unstructured":"Prokurat A, Kluge P, Ko\u015bciesza A, et al. Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol. 2002;39:510-518. https:\/\/doi.org\/10.1002\/mpo.10177","DOI":"10.1002\/mpo.10177"},{"key":"10.32074\/1591-951X-559_ref42","doi-asserted-by":"crossref","unstructured":"Sumazin P, Chen Y, Trevi\u00f1o LR, et al. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 2017;65:104-121. https:\/\/doi.org\/10.1002\/hep.28888","DOI":"10.1002\/hep.28888"},{"key":"10.32074\/1591-951X-559_ref43","doi-asserted-by":"crossref","unstructured":"Eichenm\u00fcller M, Trippel F, Kreuder M, et al. The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 2014;61:1312-1320. https:\/\/doi.org\/10.1016\/j.jhep.2014.08.009","DOI":"10.1016\/j.jhep.2014.08.009"},{"key":"10.32074\/1591-951X-559_ref44","doi-asserted-by":"crossref","unstructured":"Gr\u00f6bner SN, Worst BC, Weischenfeldt J, et al. Author Correction: The landscape of genomic alterations across childhood cancers. Nature 2018;559(7714):E10. https:\/\/doi.org\/10.1038\/s41586-018-0167-2","DOI":"10.1038\/s41586-018-0167-2"},{"key":"10.32074\/1591-951X-559_ref45","doi-asserted-by":"crossref","unstructured":"Tomlinson GE, Douglass EC, Pollock BH, et al. Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21. Genes Chromosomes Cancer 2005;44:177-184. https:\/\/doi.org\/10.1002\/gcc.20227","DOI":"10.1002\/gcc.20227"},{"key":"10.32074\/1591-951X-559_ref46","doi-asserted-by":"crossref","unstructured":"Luo JH, Ren B, Keryanov S, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006;44:1012-24. https:\/\/doi.org\/10.1002\/hep.21328","DOI":"10.1002\/hep.21328"},{"key":"10.32074\/1591-951X-559_ref47","doi-asserted-by":"crossref","unstructured":"Armengol C, Cairo S, Fabre M, et al. Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model. Int J Biochem Cell Biol 2011;43:265-270. https:\/\/doi.org\/10.1016\/j.biocel.2009.07.012","DOI":"10.1016\/j.biocel.2009.07.012"},{"key":"10.32074\/1591-951X-559_ref48","doi-asserted-by":"crossref","unstructured":"Jia D, Dong R, Jing Y, et al. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex. Hepatology 2014;60:168-1696. https:\/\/doi.org\/10.1002\/hep.27243.","DOI":"10.1002\/hep.27243"},{"key":"10.32074\/1591-951X-559_ref49","doi-asserted-by":"crossref","unstructured":"Bell D, Ranganathan S, Tao J, et al. Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt\/\u03b2-Catenin Perspective. Gene Expr. 2017; Feb;17(2):141-154. https:\/\/doi.org\/10.3727\/105221616X693639","DOI":"10.3727\/105221616X693639"},{"key":"10.32074\/1591-951X-559_ref50","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Terrada D, Gunaratne PH, Adesina AM, et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol 2009;40:783-794. https:\/\/doi.org\/10.1016\/j.humpath.2008.07.022","DOI":"10.1016\/j.humpath.2008.07.022"},{"key":"10.32074\/1591-951X-559_ref51","doi-asserted-by":"crossref","unstructured":"Ranganathan S, Ningappa M, Ashokkumar C, et al. Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma. Sci Rep 2016;6:38347. https:\/\/doi.org\/10.1038\/srep38347","DOI":"10.1038\/srep38347"},{"key":"10.32074\/1591-951X-559_ref52","doi-asserted-by":"crossref","unstructured":"Tao J, Calvisi DF, Ranganathan S, et al. Activation of \u03b2-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology 2014;147:690-701. https:\/\/doi.org\/10.1053\/j.gastro.2014.05.004","DOI":"10.1053\/j.gastro.2014.05.004"},{"key":"10.32074\/1591-951X-559_ref53","doi-asserted-by":"crossref","unstructured":"Cairo S, Armengol C, De Reynie`s A, et al. Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signalling in aggressive childhood liver cancer. Cancer Cell 2008;14:471-484. https:\/\/doi.org\/10.1016\/j.ccr.2008.11.002","DOI":"10.1016\/j.ccr.2008.11.002"},{"key":"10.32074\/1591-951X-559_ref54","doi-asserted-by":"crossref","unstructured":"Carrillo-Reixach J, Torrens L, Simon-Coma M, et al. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J Hepatol 2020;73:328-341. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.025.","DOI":"10.1016\/j.jhep.2020.03.025"},{"key":"10.32074\/1591-951X-559_ref55","doi-asserted-by":"crossref","unstructured":"Putra J, Ornvold K. Undifferentiated embryonal sarcoma of the liver: a concise review. Arch Pathol Lab Med 2015;139:269-273. https:\/\/doi.org\/10.5858\/arpa.2013-0463-RS.","DOI":"10.5858\/arpa.2013-0463-RS"},{"key":"10.32074\/1591-951X-559_ref56","doi-asserted-by":"crossref","unstructured":"Martins-Filho SN, Putra J. Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review. Hepat Oncol 2020;7(2):HEP19. https:\/\/doi.org\/10.2217\/hep-2020-0002","DOI":"10.2217\/hep-2020-0002"},{"key":"10.32074\/1591-951X-559_ref57","doi-asserted-by":"crossref","unstructured":"Stocker JT, Ishak KG. Undifferentiated (embryonal) sarcoma of the liver: report of 31 cases. Cancer 1978;42:336-48. https:\/\/doi.org\/10.1002\/1097-0142(197807)42:1<336::aid-cncr2820420151>3.0.co;2-v","DOI":"10.1002\/1097-0142(197807)42:1<336::AID-CNCR2820420151>3.0.CO;2-V"},{"key":"10.32074\/1591-951X-559_ref58","doi-asserted-by":"crossref","unstructured":"Shu B, Gong L, Huang X, et al. Undifferentiated embryonal sarcoma of the liver in adults: Retrospective analysis of a case series and systematic review. Oncol Lett 2020;20:102. https:\/\/doi.org\/10.3892\/ol.2020.11963","DOI":"10.3892\/ol.2020.11963"},{"key":"10.32074\/1591-951X-559_ref59","doi-asserted-by":"crossref","unstructured":"Setty BA, Jinesh GG, Arnold M, et al. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet 2020;16(4):e1008642. https:\/\/doi.org\/10.1371\/journal.pgen.1008642","DOI":"10.1371\/journal.pgen.1008642"},{"key":"10.32074\/1591-951X-559_ref60","doi-asserted-by":"crossref","unstructured":"Techavichit P, Masand PM, Himes RW, et al. Undifferentiated Embryonal Sarcoma of the Liver (UESL): a single-center experience and review of the literature. J Pediatr Hematol Oncol 2016;38:261-268. https:\/\/doi.org\/10.1097\/MPH.0000000000000529","DOI":"10.1097\/MPH.0000000000000529"},{"key":"10.32074\/1591-951X-559_ref61","doi-asserted-by":"crossref","unstructured":"Lenze F, Birkfellner T, Lenz P, et al. Undifferentiated embryonal sarcoma of the liver in adults. Cancer 200;112:2274-82. https:\/\/doi.org\/10.1002\/cncr.23431","DOI":"10.1002\/cncr.23431"},{"key":"10.32074\/1591-951X-559_ref62","doi-asserted-by":"crossref","unstructured":"Li XW, Gong SJ, Song WH, et al. Undifferentiated liver embryonal sarcoma in adults: a report of four cases and literature review. World J Gastroenterol 2010;16:4725-32. https:\/\/doi.org\/10.3748\/wjg.v16.i37.4725","DOI":"10.3748\/wjg.v16.i37.4725"},{"key":"10.32074\/1591-951X-559_ref63","doi-asserted-by":"crossref","unstructured":"Shehata BM, Gupta NA, Katzenstein HM, et al. Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatr Dev Pathol 2011 Mar-;14:111-6. https:\/\/doi.org\/10.2350\/09-07-0681-OA.1","DOI":"10.2350\/09-07-0681-OA.1"},{"key":"10.32074\/1591-951X-559_ref64","doi-asserted-by":"crossref","unstructured":"Mathews J, Duncavage EJ, Pfeifer JD. Characterization of translocations in mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver. Exp Mol Pathol 2013;95:319-324. https:\/\/doi.org\/10.1016\/j.yexmp.2013.09.006","DOI":"10.1016\/j.yexmp.2013.09.006"},{"key":"10.32074\/1591-951X-559_ref65","unstructured":"Cao Q, Ye Z, Chen S, et al. Undifferentiated embryonal sarcoma of liver: a multi-institutional experience with 9 cases. Int J Clin Exp Pathol 2014;7:8647-8656."},{"key":"10.32074\/1591-951X-559_ref66","doi-asserted-by":"crossref","unstructured":"Gabor F, Franchi-Abella S, Merli L, et al. Imaging features of undifferentiated embryonal sarcoma of the liver: a series of 15 children. Pediatr Radiol 2016;46:1694-1704. https:\/\/doi.org\/10.1007\/s00247-016-3670-3","DOI":"10.1007\/s00247-016-3670-3"},{"key":"10.32074\/1591-951X-559_ref67","doi-asserted-by":"crossref","unstructured":"Gomes F, Melo D, Esteves C, et al. Undifferentiated embryonal sarcoma of the liver: A rare hepatic tumor and its related characteristic radiological features. Radiol Case Rep. 2021;16:646-650. https:\/\/doi.org\/10.1016\/j.radcr.2020.12.017","DOI":"10.1016\/j.radcr.2020.12.017"},{"key":"10.32074\/1591-951X-559_ref68","doi-asserted-by":"crossref","unstructured":"Zheng JM, Tao X, Xu AM, et al. Primary and recurrent embryonal sarcoma of the liver: clinicopathological and immunohistochemical analysis. Histopathology 2007;51:195-203. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02746.x","DOI":"10.1111\/j.1365-2559.2007.02746.x"},{"key":"10.32074\/1591-951X-559_ref69","doi-asserted-by":"crossref","unstructured":"Papke DJ Jr, Fisch AS, Ranganathan S, et al. Undifferentiated embryonal sarcoma of the liver with rhabdoid morphology mimicking carcinoma: expanding the morphologic spectrum or a distinct variant? Pediatr Dev Pathol 2021:10935266211018930. https:\/\/doi.org\/10.1177\/10935266211018930","DOI":"10.1177\/10935266211018930"},{"key":"10.32074\/1591-951X-559_ref70","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-G\u00f3mez RM, Soria-C\u00e9spedes D, de Le\u00f3n-Bojorge B, et al. Diffuse membranous immunoreactivity of CD56 and paranuclear dot-like staining pattern of cytokeratins AE1\/3, CAM5.2, and OSCAR in undifferentiated (embryonal) sarcoma of the liver. Appl Immunohistochem Mol Morphol 2010;18:195-198. https:\/\/doi.org\/10.1097\/PAI.0b013e3181bb2493","DOI":"10.1097\/PAI.0b013e3181bb2493"},{"key":"10.32074\/1591-951X-559_ref71","doi-asserted-by":"crossref","unstructured":"Hu X, Chen H, Jin M, et al. Molecular cytogenetic characterization of undifferentiated embryonal sarcoma of the liver: a case report and literature review. Mol Cytogenet 2012;5:26. https:\/\/doi.org\/10.1186\/1755-8166-5-26","DOI":"10.1186\/1755-8166-5-26"},{"key":"10.32074\/1591-951X-559_ref72","doi-asserted-by":"crossref","unstructured":"Sowery RD, Jensen C, Morrison KB, et al. Comparative genomic hybridization detects multiple chromosomal amplifications and deletions in undifferentiated embryonal sarcoma of the liver. Cancer Genet Cytogenet. 2001 Apr 15;126:128-133. https:\/\/doi.org\/10.1016\/s0165-4608(00)00404-0","DOI":"10.1016\/S0165-4608(00)00404-0"},{"key":"10.32074\/1591-951X-559_ref73","doi-asserted-by":"crossref","unstructured":"Lepreux S, Rebouissou S, Le Bail B, et al. Mutation of TP53 gene is involved in carcinogenesis of hepatic undifferentiated (embryonal) sarcoma of the adult, in contrast with Wnt or telomerase pathways: an immunohistochemical study of three cases with genomic relation in two cases. J Hepatol 2005;42:424-429. https:\/\/doi.org\/10.1016\/j.jhep.2004.10.021","DOI":"10.1016\/j.jhep.2004.10.021"},{"key":"10.32074\/1591-951X-559_ref74","doi-asserted-by":"crossref","unstructured":"Habibzadeh P, Ansari Asl M, Foroutan HR, et al. Clinicopathological study of hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a single center study from Iran. Diagn Pathol 2021;16:55. https:\/\/doi.org\/10.1186\/s13000-021-01117-z","DOI":"10.1186\/s13000-021-01117-z"},{"key":"10.32074\/1591-951X-559_ref75","doi-asserted-by":"crossref","unstructured":"Ismail H, Dembowska-Bagi\u0144ska B, Broniszczak D, et al. Treatment of undifferentiated embryonal sarcoma of the liver in children--single center experience. J Pediatr Surg 2013;48:2202-2206. https:\/\/doi.org\/10.1016\/j.jpedsurg.2013.05.020","DOI":"10.1016\/j.jpedsurg.2013.05.020"},{"key":"10.32074\/1591-951X-559_ref76","doi-asserted-by":"crossref","unstructured":"Pinamonti M, Vittone F, Ghiglione F, et al. Unexpected Liver Embryonal Sarcoma in the Adult: Diagnosis and Treatment. Case Rep Surg 2018;2018:8362012. https:\/\/doi.org\/10.1155\/2018\/8362012","DOI":"10.1155\/2018\/8362012"},{"key":"10.32074\/1591-951X-559_ref77","doi-asserted-by":"crossref","unstructured":"Kim DY, Kim KH, Jung SE, et al. Undifferentiated (embryonal) sarcoma of the liver: combination treatment by surgery and chemotherapy. J Pediatr Surg 2002;37:1419-1423. https:\/\/doi.org\/10.1053\/jpsu.2002.35404","DOI":"10.1053\/jpsu.2002.35404"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:26:43Z","timestamp":1730813203000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.pathologica.it\/article\/view\/559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-559","relation":{},"ISSN":["1591-951X"],"issn-type":[{"type":"electronic","value":"1591-951X"}],"subject":[],"published":{"date-parts":[[2022,2]]},"article-number":"8"}}